Roadmap towards an institutional Impella programme for high‐risk coronary interventions

A Pietrasik, A Gąsecka, K Jasińska‐Gniadzik… - ESC heart …, 2023 - Wiley Online Library
Coronary artery disease (CAD) and its complications remain the main cause of morbidity
and mortality worldwide. Patients with extensive CAD and multiple comorbidities who …

[HTML][HTML] Quality of life in patients undergoing percutaneous coronary intervention

V Tsoulou, G Vasilopoulos, T Kapadochos… - Clinics and …, 2023 - mdpi.com
Introduction: Percutaneous coronary intervention (PCI) is a non-surgical invasive procedure
to treat coronary artery occlusion. The quality of life (QoL) is a way to measure the impact of …

The impact of heparin and direct thrombin inhibitors on cell-penetrating polymer siRNA transfection

L Mota, M Zhu, JN Tomeo, M Recarey, N Patel… - Gene Therapy, 2024 - nature.com
Gene therapy using siRNA has become a promising strategy to achieve targeted gene
knockdown for treatment of cardiovascular pathologies. However, efficient siRNA …

Model-Based Offline Reinforcement Learning for Autonomous Delivery of Guidewire

H Li, XH Zhou, XL Xie, SQ Liu, ZQ Feng… - … on Medical Robotics …, 2024 - ieeexplore.ieee.org
Guidewire delivery is a fundamental procedure in percutaneous coronary intervention. The
inherent flexibility of the guidewire poses challenges in precise control, necessitating long …